These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36989345)

  • 1. A Self-Propagating c-Met-SOX2 Axis Drives Cancer-Derived IgG Signaling That Promotes Lung Cancer Cell Stemness.
    Huang X; Zhang S; Tang J; Tian T; Pan Y; Wu L; Zhang J; Liu Y; Huang J; Dai H; Xu W; Zhang Y; Chen J; Cao M; Zhang L; Qiu X
    Cancer Res; 2023 Jun; 83(11):1866-1882. PubMed ID: 36989345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-driven IgG promotes the development of prostate cancer though the SOX2-CIgG pathway.
    Qin C; Sheng Z; Huang X; Tang J; Liu Y; Xu T; Qiu X
    Prostate; 2020 Sep; 80(13):1134-1144. PubMed ID: 32628304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung squamous cell carcinoma cells express non-canonically glycosylated IgG that activates integrin-FAK signaling.
    Tang J; Zhang J; Liu Y; Liao Q; Huang J; Geng Z; Xu W; Sheng Z; Lee G; Zhang Y; Chen J; Zhang L; Qiu X
    Cancer Lett; 2018 Aug; 430():148-159. PubMed ID: 29778566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2.
    Bora-Singhal N; Mohankumar D; Saha B; Colin CM; Lee JY; Martin MW; Zheng X; Coppola D; Chellappan S
    Sci Rep; 2020 Mar; 10(1):4722. PubMed ID: 32170113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma.
    Xiao ZJ; Liu J; Wang SQ; Zhu Y; Gao XY; Tin VP; Qin J; Wang JW; Wong MP
    Elife; 2017 Jul; 6():. PubMed ID: 28737489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug.
    Kim M; Jang K; Miller P; Picon-Ruiz M; Yeasky TM; El-Ashry D; Slingerland JM
    Oncogene; 2017 Sep; 36(36):5199-5211. PubMed ID: 28504716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11.
    Wang X; Chen Y; Wang X; Tian H; Wang Y; Jin J; Shan Z; Liu Y; Cai Z; Tong X; Luan Y; Tan X; Luan B; Ge X; Ji H; Jiang X; Wang P
    Cancer Res; 2021 Oct; 81(20):5217-5229. PubMed ID: 34385181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma.
    Justilien V; Walsh MP; Ali SA; Thompson EA; Murray NR; Fields AP
    Cancer Cell; 2014 Feb; 25(2):139-51. PubMed ID: 24525231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX2 in development and cancer biology.
    Novak D; Hüser L; Elton JJ; Umansky V; Altevogt P; Utikal J
    Semin Cancer Biol; 2020 Dec; 67(Pt 1):74-82. PubMed ID: 31412296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Putative stemness markers octamer-binding transcription factor 4, sex-determining region Y-box 2, and NANOG in non-small cell lung carcinoma: A clinicopathological association.
    Upadhyay VA; Shah KA; Makwana DP; Raval AP; Shah FD; Rawal RM
    J Cancer Res Ther; 2020; 16(4):804-810. PubMed ID: 32930122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The FBXW2-MSX2-SOX2 axis regulates stem cell property and drug resistance of cancer cells.
    Yin Y; Xie CM; Li H; Tan M; Chen G; Schiff R; Xiong X; Sun Y
    Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20528-20538. PubMed ID: 31548378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAMK2A supported tumor initiating cells of lung adenocarcinoma by upregulating SOX2 through EZH2 phosphorylation.
    Wang SQ; Liu J; Qin J; Zhu Y; Tin VP; Yam JWP; Wong MP; Xiao ZJ
    Cell Death Dis; 2020 Jun; 11(6):410. PubMed ID: 32483123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual inhibition of Src and PLK1 regulate stemness and induce apoptosis through Notch1-SOX2 signaling in EGFRvIII positive glioma stem cells (GSCs).
    Li X; Tao Z; Wang H; Deng Z; Zhou Y; Du Z
    Exp Cell Res; 2020 Nov; 396(1):112261. PubMed ID: 32896567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer.
    Xiang R; Liao D; Cheng T; Zhou H; Shi Q; Chuang TS; Markowitz D; Reisfeld RA; Luo Y
    Br J Cancer; 2011 Apr; 104(9):1410-7. PubMed ID: 21468047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAK5 promotes the cell stemness ability by phosphorylating SOX2 in lung squamous cell carcinomas.
    Bao Z; Ji W; Yang Y; Chen Z; Li Z; Wang K; Lu T; Yu Y; Xia W; Lu S
    Exp Cell Res; 2020 Oct; 395(2):112187. PubMed ID: 32721391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells.
    Rybak AP; Tang D
    Cell Signal; 2013 Dec; 25(12):2734-42. PubMed ID: 24036214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
    Bourguignon LY; Wong G; Earle C; Chen L
    J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of cancer stem cell properties, angiogenesis, and vasculogenic mimicry by miR-450a-5p/SOX2 axis in colorectal cancer.
    Chen J; Chen S; Zhuo L; Zhu Y; Zheng H
    Cell Death Dis; 2020 Mar; 11(3):173. PubMed ID: 32144236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA TDRG1 aggravates lung cancer stemness by binding to Sox2 mRNA.
    Lu Y; Cheng J; Mao Q; Wang Z; Wei Q
    Environ Toxicol; 2023 Mar; 38(3):645-653. PubMed ID: 36444968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of p38 MAPK contributes to stem cell-like properties of non-small cell lung cancer.
    Fang Y; Wang J; Wang G; Zhou C; Wang P; Zhao S; Zhao S; Huang S; Su W; Jiang P; Chang A; Xiang R; Sun P
    Oncotarget; 2017 Apr; 8(16):26702-26717. PubMed ID: 28460458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.